Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gianpaolo Tibolla

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Annual Review of Pharmacology and Toxicology|October 29, 2013
Targeting PCSK9 for hypercholesterolemiaGiuseppe Danilo Norata, Gianpaolo Tibolla, Alberico Luigi Catapano
Pharmacological Research|May 20, 2014
Statins and skeletal muscles toxicity: from clinical trials to everyday practiceGiuseppe Danilo Norata, Gianpaolo Tibolla, Alberico Luigi Catapano
Trends in Pharmacological Sciences|March 15, 2013
Gene silencing approaches for the management of dyslipidaemiaGiuseppe Danilo Norata, Gianpaolo Tibolla, Alberico Luigi Catapano
Vascular Pharmacology|June 14, 2014
PCSK9 inhibition for the treatment of hypercholesterolemia: promises and emerging challengesGiuseppe Danilo Norata, Gianpaolo Tibolla, Alberico Luigi Catapano
Current Atherosclerosis Reports|June 4, 2014
HDL: to treat or not to treat?Angela Pirillo, Gianpaolo Tibolla, Giuseppe Danilo Norata, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 2005
Dihydrotestosterone decreases tumor necrosis factor-alpha and lipopolysaccharide-induced inflammatory response in human endothelial cellsGiuseppe Danilo Norata, Gianpaolo Tibolla, Paul Maria Seccomandi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 4, 2008
Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general populationGiuseppe Danilo Norata, Katia Garlaschelli, Liliana Grigore, et al.
Atherosclerosis|December 20, 2011
Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levelsNicola Ferri, Gianpaolo Tibolla, Angela Pirillo, et al.
Plos One|May 1, 2015
IDOL N342S Variant, Atherosclerosis Progression and Cardiovascular Disorders in the Italian General PopulationAshish Dhyani, Gianpaolo Tibolla, Andrea Baragetti, et al.
Atherosclerosis|August 2, 2016
PCSK9 knock-out mice are protected from neointimal formation in response to perivascular carotid collar placementNicola Ferri, Silvia Marchianò, Gianpaolo Tibolla, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Annual Review of Pharmacology and Toxicology|October 29, 2013
Targeting PCSK9 for hypercholesterolemiaGiuseppe Danilo Norata, Gianpaolo Tibolla, Alberico Luigi Catapano
Pharmacological Research|May 20, 2014
Statins and skeletal muscles toxicity: from clinical trials to everyday practiceGiuseppe Danilo Norata, Gianpaolo Tibolla, Alberico Luigi Catapano
Trends in Pharmacological Sciences|March 15, 2013
Gene silencing approaches for the management of dyslipidaemiaGiuseppe Danilo Norata, Gianpaolo Tibolla, Alberico Luigi Catapano
Vascular Pharmacology|June 14, 2014
PCSK9 inhibition for the treatment of hypercholesterolemia: promises and emerging challengesGiuseppe Danilo Norata, Gianpaolo Tibolla, Alberico Luigi Catapano
Current Atherosclerosis Reports|June 4, 2014
HDL: to treat or not to treat?Angela Pirillo, Gianpaolo Tibolla, Giuseppe Danilo Norata, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 2005
Dihydrotestosterone decreases tumor necrosis factor-alpha and lipopolysaccharide-induced inflammatory response in human endothelial cellsGiuseppe Danilo Norata, Gianpaolo Tibolla, Paul Maria Seccomandi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 4, 2008
Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general populationGiuseppe Danilo Norata, Katia Garlaschelli, Liliana Grigore, et al.
Atherosclerosis|December 20, 2011
Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levelsNicola Ferri, Gianpaolo Tibolla, Angela Pirillo, et al.
Plos One|May 1, 2015
IDOL N342S Variant, Atherosclerosis Progression and Cardiovascular Disorders in the Italian General PopulationAshish Dhyani, Gianpaolo Tibolla, Andrea Baragetti, et al.
Atherosclerosis|August 2, 2016
PCSK9 knock-out mice are protected from neointimal formation in response to perivascular carotid collar placementNicola Ferri, Silvia Marchianò, Gianpaolo Tibolla, et al.
Pageof 2